• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. STEALTH 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. STEALTH 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE Back to Search Results
Model Number PRD-SC30-MICRO
Device Problem Mechanical Problem (1384)
Patient Problem Perforation of Vessels (2135)
Event Date 02/07/2020
Event Type  Injury  
Manufacturer Narrative
The reported oad was received for analysis.Adhered biological material was observed on the crown of the oad.Examination of the area of adhered material did not reveal any damage.The morphology and root cause of the biological material was unknown.No damage to the driveshaft or crown that could have contributed to the perforation was observed.A guide wire was passed through the area of adhered material with no resistance.The oad spun at all speeds and functioned as intended.The data logs of the oad showed that a motor stall occurred.At the conclusion of the device analysis, the reported event of a perforation was unable to be conclusively confirmed.The log report of an oad stall may have been related to the event of the oad slowing down, however, this was unable to be conclusively confirmed.The device history record for this oad lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.(b)(4).
 
Event Description
During a procedure with a stealth peripheral orbital atherectomy device (oad), a perforation occurred.The 100% occluded, heavily calcified lesion was located along the entire length of the posterior tibial artery (pt) and was treated on medium speed with the oad.The oad started to lose power and perforation occurred.The perforation was treated with balloon tamponade, and the procedure was delayed by greater than thirty (30) minutes.Pain medications were administered to the patient, a blood pressure cuff was applied.The patient was stable following the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STEALTH 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
Type of Device
PERIPHERAL ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
saint paul, mn
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
saint paul, mn
Manufacturer Contact
sarah hicks
1225 old highway 8 nw
saint paul, mn 
MDR Report Key9781622
MDR Text Key181817303
Report Number3004742232-2020-00061
Device Sequence Number1
Product Code MCW
UDI-Device Identifier10850000491264
UDI-Public(01)10850000491264(17)210831(10)287247
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190634
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 03/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2021
Device Model NumberPRD-SC30-MICRO
Device Catalogue Number7-10059-01
Device Lot Number287247
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/13/2020
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/07/2020
Initial Date FDA Received03/03/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/28/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient Weight77
-
-